Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AURKA | O14965 | 3/20 | 0.37 |
| ▸ | TPX2 | Q9ULW0 | 3/20 | 0.37 |
| ▸ | GRM5 | P41594 | 1/20 | 0.34 |
| ▸ | DAO | P14920 | 1/20 | 0.33 |
| ▸ | DDO | Q99489 | 1/20 | 0.33 |
| ▸ | CCR8 | P51685 | 1/20 | 0.33 |
| ▸ | CFB | P00751 | 1/20 | 0.33 |
| ▸ | P2RX7 | Q99572 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | LDHA | P00338 | 2/20 | 0.32 |
| ▸ | LDHB | P07195 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.31 |
| ▸ | HPGD | P15428 | 3/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | PARP1 | P09874 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15102902 | 0.83 | CCR8 (0.40) | AURKATPX2GRM5CCR8CFB | |
| SCHEMBL13018018 | 0.79 | PADI4 (0.35) | AURKATPX2GRM5CCR8P2RX7 | |
| SCHEMBL11912884 | 0.78 | CCR8 (0.37) | AURKATPX2GRM5CCR8CFB | |
| SCHEMBL4419258 | 0.72 | CCR8 (0.46) | CCR8KMT2AKDM4EALDH1A1CYP3A4 | |
| SCHEMBL4418773 | 0.72 | CCR8 (0.40) | CCR8KMT2AKDM4EALDH1A1CYP3A4 | |
| SCHEMBL24136691 | 0.71 | PARP1 (0.43) | DAODDOKMT2AKDM4EALDH1A1 | |
| SCHEMBL30466409 | 0.71 | PARP1 (0.43) | DAODDOKMT2AKDM4EALDH1A1 | |
| SCHEMBL18876055 | 0.70 | CFB (0.41) | AURKATPX2CCR8CFBP2RX7 | |
| SCHEMBL30954322 | 0.70 | AURKA (0.36) | AURKATPX2DAOP2RX7KMT2A | |
| SCHEMBL19186888 | 0.68 | DAO (0.38) | DAODDOKMT2AKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11658311-B2 | Cathode for lithium air battery comprising hollow structure and method of manufacturing same | HYUNDAI MOTOR COMPANY (KR) | 2023-05-23 | — | — | US | disclosed |
| US-20180200680-A1 | Composite Membrane and Method of Fabricating the Same | CO2 M-TECH CO., LTD. (JP) | 2018-07-19 | — | — | US | disclosed |
| US-20170266123-A1 | COATED PARTICLES FOR DRUG DELIVERY | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2017-09-21 | — | — | US | disclosed |
| US-9637597-B2 | DOPA-melanin formation in high ionic strength solutions | NORTHWESTERN UNIVERSITY (US) | 2017-05-02 | — | — | US | disclosed |
| US-20140058184-A1 | USE OF NEURAL STEM CELLS FOR TREATMENT OF MALIGNANCY | CRAWFORD SUSAN E (US) | 2014-02-27 | — | — | US | disclosed |
| US-20140058184-A1 | USE OF NEURAL STEM CELLS FOR TREATMENT OF MALIGNANCY | CRAWFORD SUSAN E (US) | 2014-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140058184-A1 | USE OF NEURAL STEM CELLS FOR TREATMENT OF MALIGNANCY | NES, L1CAM, EPCAM | AURKA 1163/4885TPX2 1252/4885GRM5 3400/4885 |
| US-20170266123-A1 | COATED PARTICLES FOR DRUG DELIVERY | EPCAM, SELP, CAPG | AURKA 154/4885TPX2 2651/4885GRM5 1825/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.